Emerald Bioscience to Present at the 2019 H.C. Wainwright Global Life Sciences Conference
April 08, 2019 08:30 ET
|
Emerald Bioscience, Inc.
LONG BEACH, CA, April 08, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Emerald Bioscience, Inc. (OTCQB: EMBI), a biopharmaceutical company focused on developing bioengineered cannabinoid-based...
InspireMD to Present at the H.C. Wainwright 20th Annual Global Investment Conference in New York City
September 04, 2018 07:30 ET
|
InspireMD, Inc.
TEL AVIV, ISRAEL, Sept. 04, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE - InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke...
Jounce Therapeutics to Present at Upcoming Investor Conferences in September
August 29, 2018 08:00 ET
|
Jounce Therapeutics, Inc.
CAMBRIDGE, Mass., Aug. 29, 2018 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical stage company focused on the discovery and development of novel cancer immunotherapies and...
VBI Vaccines to Present at the 20th Annual Rodman & Renshaw Global Investment Conference
August 28, 2018 08:00 ET
|
VBI Vaccines, Inc.
CAMBRIDGE, Mass., Aug. 28, 2018 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (NASDAQ:VBIV) (“VBI”), a commercial-stage biopharmaceutical company developing next-generation infectious disease and...
Galectin Therapeutics to Present at H.C. Wainwright Global Life Sciences Conference
April 02, 2018 10:20 ET
|
Galectin Therapeutics Inc.
NORCROSS, Ga., April 02, 2018 (GLOBE NEWSWIRE) --
Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins, today announced that...